TiumBio Revenue

Biotechnology Research • 6F, Pangyo IT Center, Korea, Republic of • 11-20 Employees

TiumBio revenue & valuation

Annual revenue	$7,232,753
Revenue per employee	$557,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$23,200,000
Total funding	$15,400,000

Key Contact at TiumBio

Minsun Lee

Research Fellowdirector

Company overview

Headquarters	6F, Pangyo IT Center, 30 Changup-ro 40 beon-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do 13449, KR
Phone number	+82316001500
Website	tiumbio.com
NAICS	541714
SIC	283
Keywords	Women'S Health, Development, Discovery, Rare Diseases, Small Molecules, Hemophilia, Immuno-Oncology, Endometiosis
Founded	2016
Employees	11-20
Socials

TiumBio Email Formats

TiumBio uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@tiumbio.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@tiumbio.com	100%

About TiumBio

TiumBio (KOSDAQ: 321550) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics for patients with rare and incurable diseases. Our mission is to enhance the hope and happiness of humanity through scientific advancements. TiumBio currently has three leading pipeline assets in clinical trials, with TU2218 being investigated in Phase 2 and TU2670 and TU7710 in Phase 1. TU2218 is an oral immuno-oncology therapy targeting TGF-beta and VEGFR2, while TU2670 is an orally active non-peptide GnRH antagonist. Additionally, TU7710 is a bypass-factor treatment specifically designed for hemophilia patients who have developed neutralizing antibodies. TiumBio is located in Seongnam-si, South Korea and has three subsidiaries including Boston-based biotechnology company, Initium Therapeutics and a CDO compnay, Protium Science. For any media inquiry or investor relations, contact ir@tiumbio.com

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Manager

Entry

Head

Employees by Department

TiumBio has 5 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore TiumBio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-01-29	14	$15,400,000

Funding Insights

$15,400,000

Total funding amount

$15,400,000

Most recent funding amount

Number of funding rounds

TiumBio Tech Stack

Discover the technologies and tools that power TiumBio's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery CDN

CDN

Lodash

JavaScript libraries

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

Slick

JavaScript libraries

PHP

Programming languages

Open Graph

Miscellaneous

GSAP

JavaScript frameworks

jQuery UI

JavaScript libraries

Google Font API

Font scripts

jQuery Migrate

JavaScript libraries

Frequently asked questions

TiumBio is located in 6F, Pangyo IT Center, KR.

You can reach TiumBio at +82316001500.

TiumBio generates an estimated annual revenue of $7,232,753. This revenue figure reflects the company's market position and business performance in its industry.

TiumBio has an estimated valuation of $23,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

TiumBio was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

TiumBio has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

TiumBio has raised a total of $15,400,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at TiumBio

Minsun Lee

Research Fellowdirector

4.8

40,000 users